NewsRx

Search our medical news database

Conference Coverage (Retrovirus)

CD4 Count Still Best Marker of Immune Function

Published in Vaccine Weekly, March 3rd, 1997

CD4 count - long used by AIDS clinicians to track HIV disease progression - is still the best surrogate marker for immune function.

Sensitive new measures of HIV viral load provide a wealth of information on disease progression. These new tests may be the most sensitive measure of how well an individual is doing in his or her struggle with the AIDS virus.

But data obtained in a Phase II clinical trial of the Genentech candidate HIV vaccine show that a patient's CD4 count remains the best mark of immune function.

"Although HIV replication drives CD4-cell loss, CD4 count is a better marker of immunologic function than plasma HIV-1...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook